BACKGROUND: Platelet Endothelial Aggregation Receptor-1 (PEAR1) is a transmembrane platelet receptor that amplifies the activation of the platelet fibrinogen receptor (αIIbβ3) during platelet aggregation. In man, Pear1 polymorphisms are associated with changes in platelet aggregability. In this report, we characterized Pear1 expression and function in murine platelets. METHODS: Pear1 phosphorylation and signaling, platelet aggregation, α-degranulation and clot retraction were studied in WT and Pear1-/- platelets. The function of Pear1 in haemostasis and thrombosis was studied in a mouse tail vein bleeding and ferric chloride-induced mesenteric thrombosis model. RESULTS: Mature murine platelets express Pear1 on their membrane and clustering of Pear1 by anti-Pear1 antibodies triggered platelet aggregation. Pear1 was weakly phosphorylated during collagen-induced murine platelet aggregation and was translocated to the cytoskeleton. Absence of murine Pear1 impaired dextran sulfate-induced platelet aggregation, but did not impact collagen-, AYPGK and ADP-induced platelet aggregation, coupled to a lower Pear1 expression in murine than in human platelets and to weaker Pear1-mediated downstream signaling. Neither clot retraction nor α-degranulation was affected in Pear1-/- mice. Likewise, in vivo tests like the tail vein bleeding time and thrombus formation in mesenteric veins were similar in WT and Pear1-/- mice. CONCLUSION: Murine platelet Pear1 shares a number of characteristics with human platelet PEAR1. Nevertheless, murine Pear1 contributes less to platelet function as does human PEAR1 and does not overtly impact haemostasis and thrombosis in mice.
BACKGROUND:Platelet Endothelial Aggregation Receptor-1 (PEAR1) is a transmembrane platelet receptor that amplifies the activation of the platelet fibrinogen receptor (αIIbβ3) during platelet aggregation. In man, Pear1 polymorphisms are associated with changes in platelet aggregability. In this report, we characterized Pear1 expression and function in murine platelets. METHODS:Pear1 phosphorylation and signaling, platelet aggregation, α-degranulation and clot retraction were studied in WT and Pear1-/- platelets. The function of Pear1 in haemostasis and thrombosis was studied in a mouse tail vein bleeding and ferric chloride-induced mesenteric thrombosis model. RESULTS: Mature murine platelets express Pear1 on their membrane and clustering of Pear1 by anti-Pear1 antibodies triggered platelet aggregation. Pear1 was weakly phosphorylated during collagen-induced murineplatelet aggregation and was translocated to the cytoskeleton. Absence of murinePear1 impaired dextran sulfate-induced platelet aggregation, but did not impact collagen-, AYPGK and ADP-induced platelet aggregation, coupled to a lower Pear1 expression in murine than in human platelets and to weaker Pear1-mediated downstream signaling. Neither clot retraction nor α-degranulation was affected in Pear1-/- mice. Likewise, in vivo tests like the tail vein bleeding time and thrombus formation in mesenteric veins were similar in WT and Pear1-/- mice. CONCLUSION:Murine platelet Pear1 shares a number of characteristics with human platelet PEAR1. Nevertheless, murinePear1 contributes less to platelet function as does humanPEAR1 and does not overtly impact haemostasis and thrombosis in mice.
Authors: Daniel Bottomly; Nicola Long; Anna Reister Schultz; Stephen E Kurtz; Cristina E Tognon; Kara Johnson; Melissa Abel; Anupriya Agarwal; Sammantha Avaylon; Erik Benton; Aurora Blucher; Uma Borate; Theodore P Braun; Jordana Brown; Jade Bryant; Russell Burke; Amy Carlos; Bill H Chang; Hyun Jun Cho; Stephen Christy; Cody Coblentz; Aaron M Cohen; Amanda d'Almeida; Rachel Cook; Alexey Danilov; Kim-Hien T Dao; Michie Degnin; James Dibb; Christopher A Eide; Isabel English; Stuart Hagler; Heath Harrelson; Rachel Henson; Hibery Ho; Sunil K Joshi; Brian Junio; Andy Kaempf; Yoko Kosaka; Ted Laderas; Matt Lawhead; Hyunjung Lee; Jessica T Leonard; Chenwei Lin; Evan F Lind; Selina Qiuying Liu; Pierrette Lo; Marc M Loriaux; Samuel Luty; Julia E Maxson; Tara Macey; Jacqueline Martinez; Jessica Minnier; Andrea Monteblanco; Motomi Mori; Quinlan Morrow; Dylan Nelson; Justin Ramsdill; Angela Rofelty; Alexandra Rogers; Kyle A Romine; Peter Ryabinin; Jennifer N Saultz; David A Sampson; Samantha L Savage; Robert Schuff; Robert Searles; Rebecca L Smith; Stephen E Spurgeon; Tyler Sweeney; Ronan T Swords; Aashis Thapa; Karina Thiel-Klare; Elie Traer; Jake Wagner; Beth Wilmot; Joelle Wolf; Guanming Wu; Amy Yates; Haijiao Zhang; Christopher R Cogle; Robert H Collins; Michael W Deininger; Christopher S Hourigan; Craig T Jordan; Tara L Lin; Micaela E Martinez; Rachel R Pallapati; Daniel A Pollyea; Anthony D Pomicter; Justin M Watts; Scott J Weir; Brian J Druker; Shannon K McWeeney; Jeffrey W Tyner Journal: Cancer Cell Date: 2022-07-21 Impact factor: 38.585
Authors: Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård Journal: Blood Adv Date: 2019-02-12